China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 23.85

From 52W high−22.70%

Volume7.69M

Market capCNY 39.28B

P/E (TTM)11.5x

P/S (TTM)1.2x

Div yield4.41%

Key dataSep 18, 2026

Open

CNY 23.85

From 52W high

−22.70%

Volume

7.69M

Market cap

CNY 39.28B

ValuationView details →

P/E (Fwd)

10.1x

EV/EBITDA

9.4x

P/E (TTM)

11.5x

RSI (14)

39.0

MomentumView details →

1D Return

−2.24%

YTD Return

−17.08%

ValuationView details →

P/E (Fwd)

10.1x

P/E (TTM)

11.5x

EV/EBITDA

9.4x

EV/Sales

1.8x

P/S (TTM)

1.2x

P/B (TTM)

1.7x

ProfitabilityView details →

Gross Margin

55.09%

Net Margin

9.81%

EBITDA Margin

18.67%

ROE (TTM)

13.88%

ROA (TTM)

5.55%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+20.98%

EPS YoY

−1.45%

FCF YoY

+12.41%

Revenue CAGR 3Y

+20.46%

EPS CAGR 3Y

−6.00%

EBITDA YoY

—

MomentumView details →

1D Return

−2.24%

YTD Return

−17.08%

1Y Return

−17.94%

RSI (14)

39.0

vs 50D SMA

−4.81%

vs 200D SMA

−11.10%

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

2.03x

Quick Ratio

1.58x

Div Yield

4.41%

Div Rate

CNY 1.04

Div Growth 1Y

−63.80%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.43

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

32.88B

Net Income (TTM)

3.23B

Op. CF (TTM)

5.59B

Next earningsOct 26, 2026 →

Latest newsMore news →

China Resources Pharmaceutical's subsidiary China Resources Sanjiu received approval from the National Medical Products Administration to launch mupirocin ointment in mainland China.9d ago

China Resources Sanjiu held an investor research meeting on September 4, 2026, in connection with its 2026 interim results briefing, attended by its chairman, president, CFO, and other executives.16d ago

Similar companies

太阳纸业002078.SZ 中矿资源002738.SZ 联合动力301656.SZ 联特科技301205.SZ 南大光电300346.SZ 华利集团300979.SZ Find similar companies →

Latest newsMore news →

China Resources Pharmaceutical's subsidiary China Resources Sanjiu received approval from the National Medical Products Administration to launch mupirocin ointment in mainland China.9d ago China Resources Sanjiu held an investor research meeting on September 4, 2026, in connection with its 2026 interim results briefing, attended by its chairman, president, CFO, and other executives.16d ago China Resources Sanjiu disclosed its semi-annual report on August 21, reporting net profit attributable to shareholders of 1.671 billion yuan, down 7.96% year-on-year.30d ago